Press releases

Older releases

Latest reports

All reports

Calendar

All events

Share

Read more

Initiator Pharma Numbers

  • Expected Number of men affected by Erectile Dysfunction worldwide by 2025 322 million
  • Number of people worldwide that are diagnosed with Trigeminal Neuralgia every year: 15000
  • Men with Erectile Dysfunction who do not respond to drug therapy 40 %
Initiatorpharma-module-homepage-1-22102021

Initiator Pharma currently has a portfolio of four projects, of which two are in clinical development and two are in preclinical development.

View our Pipeline

CEO letter

Thanks to a successful capitalization of the company via directed share issues and a fully guaranteed rights issue at the end of June, we entered the third quarter with secured financing well into 2024 allowing us to continue the advancement of all our clinical programs according to our overall plans and priorities.

Read the full letter
Initiatorpharma-module-homepage-2-22102021

Mono-amine transporters is a unique class of proteins that are located just outside the synaptic cleft (peri-synaptically), transporting monoamine transmitter overflow from the synaptic cleft back to the cytoplasm of the pre-synaptic neuron.

Read more about our technology